Marc Rendell - Concepedia

Author

Marc Rendell

Also Known As

Efrain Reisin, Heptulla, Rubina, M RENDELL, M Rendell, M S Rendell, M. Phillips, M. RENDELL, M. Rendell, M. S. Rendell, M.S Rendell

254

Publications

9.9K

Citations

H-Index

127

Concepts

All Affiliations

Creighton University Johns Hopkins University National Institutes of Health Lund University Dallas Diabetes Research Center

About

Marc Rendell is an author at Creighton University specializing in medicine, diabetes, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	48	3.5K
2	Health Sciences	11	11	508
3	Natural Sciences	7	7	468
4	Engineering	1	1	10
5	Public Health	1	1	41

Marc Rendell

Publications

7.8K

Citations

H-Index

Page 1

	Year	Citations
Sildenafil for Treatment of Erectile Dysfunction in Men With Diabetes Marc Rendell, Jacob Rajfer, Pierre Wicker, JAMA	1999	619
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, The Lancet UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes	2019	589
Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study Daniel Einhorn, Marc Rendell, James L. Rosenzweig, Clinical Therapeutics Metabolic SyndromeDiabetes ManagementMedicineDiabetesType 2	2000	369
Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy Stuart C. Apfel, Sherwin Schwartz, Bruce T. Adornato, JAMA	2000	354
A Randomized Trial of Rosiglitazone Therapy in Patients With Inadequately Controlled Insulin-Treated Type 2 Diabetes Philip Raskin, Marc Rendell, Matthew C. Riddle, Diabetes Care	2001	343
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients Mark Rigby, Kristina M. Harris, Ashley Pinckney, Journal of Clinical Investigation	2015	286
Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study Mark Kipnes, Arthur Krosnick, Marc Rendell, The American Journal of Medicine Diabetes ManagementMedicineDiabetesType 2Clinical Pharmacology	2001	280
A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type 2 Diabetes Martin St. John Sutton, Marc Rendell, Paresh Dandona, Diabetes Care	2002	254
The Dawn Phenomenon, an Early Morning Glucose Rise: Implications for Diabetic Intraday Blood Glucose Variation María Inês Schmidt, Angeliki Hadji-Georgopoulos, Marc Rendell, Diabetes Care SleepDiabetes ManagementMedicineInsulin ManagementPhysiology	1981	215
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes Arthur Sands, Brian Zambrowicz, Julio Rosenstock, Diabetes Care	2015	212

Page 1